Psychedelics Move to The Forefront of Innovative Research as the FDA Approves Large-Scale Testing
Psychedelics are quietly being used in clinical settings on small numbers of patients, but they are moving quickly toward medical approval. The FDA recently approved large-scale human trials to determine whether MDMA and other psychedelics ... [Read]
Psychedelics Transition from Experimental Treatment to Major Pharmaceutical Industry
Psychedelic medicine is emerging as a breakthrough for mental health. After decades of research, drugs like psilocybin and ketamine are finally ready to move from the lab into the pharmacy and the therapist’s office. Several ... [Read]
Psychedelic Therapies Become New Biotech Hotspot Amid New Legitimacy
For decades, psychedelic therapy was only an experimental idea under research by organizations at academic institutions including Johns Hopkins. This changed in 2018 after life sciences company COMPASS Pathways plc (NASDAQ:CMPS) received Breakthrough Therapy Designation ... [Read]